Structure based drug design: Selective inhibitors of CDC2 and CDK2

被引:0
|
作者
Brooks, FE [1 ]
Lum, R [1 ]
Mackman, R [1 ]
Joly, A [1 ]
Shiffman, D [1 ]
机构
[1] CV Therapeut, Palo Alto, CA 94304 USA
来源
FASEB JOURNAL | 1997年 / 11卷 / 09期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2121
引用
收藏
页码:A1220 / A1220
页数:1
相关论文
共 50 条
  • [1] Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells
    Yamamoto, H
    Monden, T
    Miyoshi, H
    Izawa, H
    Ikeda, K
    Tsujie, M
    Ohnishi, T
    Sekimoto, M
    Tomita, N
    Monden, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (02) : 233 - 239
  • [2] BUTYROLACTONE-I, A SELECTIVE INHIBITOR OF CDK2 AND CDC2 KINASE
    KITAGAWA, M
    OKABE, T
    OGINO, H
    MATSUMOTO, H
    SUZUKITAKAHASHI, I
    KOKUBO, T
    HIGASHI, H
    SAITOH, S
    TAYA, Y
    YASUDA, H
    OHBA, Y
    NISHIMURA, S
    TANAKA, N
    OKUYAMA, A
    ONCOGENE, 1993, 8 (09) : 2425 - 2432
  • [3] THE CHARACTERIZATION OF HUMAN CDC2 KINASE AND CDK2
    YASUDA, H
    KAMIJO, M
    OHBA, Y
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1993, 113 (12): : 829 - 846
  • [4] Differential regulation of Cdc2 and Cdk2 by RINGO and Cyclins
    Karaiskou, A
    Perez, LH
    Ferby, I
    Ozon, R
    Jessus, C
    Nebreda, AR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) : 36028 - 36034
  • [5] Cdk2 and Cdk4 cooperatively control the expression of Cdc2
    Cyril Berthet
    Philipp Kaldis
    Cell Division, 1
  • [6] GENOMIC ORGANIZATION OF MURINE HOMOLOGS OF CDC2 AND CDK2
    JUN, D
    PARK, HK
    LEE, YH
    KIM, Y
    NAGEL, J
    NORDIN, A
    FASEB JOURNAL, 1995, 9 (03): : A233 - A233
  • [7] Cdk2 and Cdk4 cooperatively control the expression of Cdc2
    Berthet, Cyril
    Kaldis, Philipp
    CELL DIVISION, 2006, 1 (1)
  • [8] Amplified CDK2 and cdc2 activities in primary colorectal carcinoma
    Kim, JH
    Kang, MJ
    Park, CU
    Kwak, HJ
    Hwang, Y
    Koh, GY
    CANCER, 1999, 85 (03) : 546 - 553
  • [9] EFFECTS OF PHOSPHORYLATION BY CAK ON CYCLIN BINDING BY CDC2 AND CDK2
    DESAI, D
    WESSLING, HC
    FISHER, RP
    MORGAN, DO
    MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (01) : 345 - 350
  • [10] Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors
    Vulpetti, A
    Casale, E
    Roletto, F
    Amici, R
    Villa, M
    Pevarello, P
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2006, 24 (05): : 341 - 348